SEC Filings - MiNK Therapeutics

Form	Description	Filing date	View
CORRESP	CORRESP	Oct 12, 2021	View HTML 0001193125-21-296966.pdf 0001193125-21-296966.rtf 0001193125-21-296966.xls
CORRESP	CORRESP	Oct 12, 2021	View HTML 0001193125-21-296972.pdf 0001193125-21-296972.rtf 0001193125-21-296972.xls
CORRESP	CORRESP	Sep 13, 2021	View HTML 0001193125-21-271924.pdf 0001193125-21-271924.rtf 0001193125-21-271924.xls
CORRESP	CORRESP	Sep 24, 2021	View HTML 0001193125-21-282464.pdf 0001193125-21-282464.rtf 0001193125-21-282464.xls
CORRESP	CORRESP	Nov 07, 2022	View HTML 0001193125-22-278982.pdf 0001193125-22-278982.rtf 0001193125-22-278982.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Apr 29, 2022	View HTML 0001193125-22-133970.pdf 0001193125-22-133970.rtf 0001193125-22-133970.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	May 01, 2023	View HTML 0000950170-23-016187.pdf 0000950170-23-016187.rtf 0000950170-23-016187.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Apr 29, 2024	View HTML 0000950170-24-050064.pdf 0000950170-24-050064.rtf 0000950170-24-050064.xls
DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	Jan 22, 2021	View HTML 0000950123-21-000524.pdf 0000950123-21-000524.rtf 0000950123-21-000524.xls
DRS/A	Amendment to a previously filed DRS	Jul 28, 2021	View HTML 0000950123-21-009292.pdf 0000950123-21-009292.rtf 0000950123-21-009292.xls

Data provided by Kaleidoscope.